Zions Bancorporation, National Association’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.17M Buy
5,146
+1,871
+57% +$1.91M 0.37% 46
2026
Q1
$3.01M Sell
3,275
-2,743
-46% -$2.78M 0.19% 75
2025
Q4
$6.47M Buy
6,018
+557
+10% +$533K 0.3% 52
2025
Q3
$4.17M Sell
5,461
-7,882
-59% -$5.87M 0.21% 80
2025
Q2
$10.4M Sell
13,343
-15
-0.1% -$11.7K 0.56% 28
2025
Q1
$11M Buy
+13,358
New +$11.1M 0.7% 21

Other funds holding LLY

Zions Bancorporation, National Association's LLY Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Eli Lilly (LLY) stake by 57% in Q2 2026, buying an estimated $1.91M and bringing the position to 5,146 shares worth $6.17M. The position accounts for 0.37% of the portfolio, ranked #46.

Zions Bancorporation, National Association first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $11M in Q1 2025. 2,244 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Zions Bancorporation, National Association held 5,146 shares of Eli Lilly worth $6.17M as of Q2 2026.
  • Zions Bancorporation, National Association bought 1,871 Eli Lilly shares in Q2 2026, an estimated $1.91M.
  • Eli Lilly made up 0.37% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #46 holding.
  • Zions Bancorporation, National Association first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Eli Lilly position peaked at $11M in Q1 2025.
  • 2,244 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.